To investigate how WNT5B gain-of-function affects HD pathogenesis in vivo, we delivered AAV-GFAP(pro)-WNT5B into the striatum of N171-82Q mice via bilateral stereotaxic injection (Fig. 5a). Here, GFAP is linked to Huntington disease.